These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 14371701)

  • 1. Attenuation of isoniazid-resistant mutants of tubercle bacilli and host hypersensitivity to tuberculin.
    MIDDLEBROOK G; COHN ML
    Proc Soc Exp Biol Med; 1955 Apr; 88(4):568-71. PubMed ID: 14371701
    [No Abstract]   [Full Text] [Related]  

  • 2. Attenuation of highly isoniazid-resistant tubercle bacilli.
    HIRANO N; NAKANISHI K; FUKUNAGA K
    Yokohama Med Bull; 1955 Aug; 6(4):196-202. PubMed ID: 13300158
    [No Abstract]   [Full Text] [Related]  

  • 3. Observations on the pathogenicity of isoniazid-resistant mutants of tubercle bacilli for tuberculous patients.
    OESTREICHER R; DRESSLER SH; RUSSELL WF; GROW JB; MIDDLEBROOK G
    Am Rev Tuberc; 1955 Mar; 71(3, Part 1):390-405. PubMed ID: 14350199
    [No Abstract]   [Full Text] [Related]  

  • 4. The virulence of isoniazid resistant tubercle bacilli, recovered from patients during treatment.
    MEISSNER G
    Dis Chest; 1954 Jul; 26(1):15-26. PubMed ID: 13173335
    [No Abstract]   [Full Text] [Related]  

  • 5. The pyrazinamide susceptibility of isoniazid-resistant mutants of tubercle bacilli.
    PERRY CR; MORSE WC
    Am Rev Tuberc; 1955 Dec; 72(6):840-2. PubMed ID: 13268854
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies on isoniazid and tubercle bacilli. I. The isolation of isoniazid-resistant mutants in vitro.
    COHN ML; ODA U; KOVITZ C; MIDDLEBROOK G
    Am Rev Tuberc; 1954 Sep; 70(3):465-75. PubMed ID: 13189061
    [No Abstract]   [Full Text] [Related]  

  • 7. Experimental study on the influence of azo-tuberculin upon guinea pigs infected with tubercle bacilli. IV. Comparative study on the skin-reacting potencies of o-aminophenol azo-tuberculin derivatives of different strains of Mycobacterium tuberculosis.
    ITO R; MIYAGI T; KISHI T
    Jpn J Med; 1950 Dec; 3(6):373-9. PubMed ID: 14880341
    [No Abstract]   [Full Text] [Related]  

  • 8. Regression of tuberculous lesions in guinea pigs infected with isoniazid-resistant tubercle bacilli.
    KARLSON AG
    Am Rev Tuberc; 1954 Sep; 70(3):531-2. PubMed ID: 13189071
    [No Abstract]   [Full Text] [Related]  

  • 9. [Tuberculin allergy induced in bovines by injection of tubercle bacilli rendered avirulent by formol and heat and suspended in aluminum hydroxide; consequences].
    ROMAN G; DEBRE R; RICHOU R; COSTIL L; THIERY JP; GERBEAUX C
    C R Hebd Seances Acad Sci; 1951 Sep; 233(10):566-8. PubMed ID: 14870391
    [No Abstract]   [Full Text] [Related]  

  • 10. [New chemical methods for rapid differentiation of isoniazid-sensitive and isoniazid-resistant tubercle bacilli].
    VISCHER WA; TIRUNARAYANAN MO; BRUHIN H
    Schweiz Z Pathol Bakteriol; 1959; 22():577-88. PubMed ID: 13842455
    [No Abstract]   [Full Text] [Related]  

  • 11. [On the virulence of chemoresistant tubercle bacilli. II. Tubercle bacilli which have become resistant to isoniazid in vivo].
    MEISSNER G
    Beitr Klin Tuberk Spezif Tuberkuloseforsch; 1954; 110(6):538-46. PubMed ID: 13159801
    [No Abstract]   [Full Text] [Related]  

  • 12. The altered growth characteristics of isoniazid-resistant tubercle bacilli.
    FISHER MW; MONTROSS FL; PALECEK NM
    Am Rev Tuberc; 1952 Nov; 66(5):626-8. PubMed ID: 12986202
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies on isoniazid and tubercle bacilli. II. The growth requirements, catalase activities, and pathogenic properties of isoniazid-resistant mutants.
    COHN ML; KOVITZ C; ODA U; MIDDLEBROOK G
    Am Rev Tuberc; 1954 Oct; 70(4):641-64. PubMed ID: 13197742
    [No Abstract]   [Full Text] [Related]  

  • 14. [Virulence of isoniazid-resistant tubercle bacilli in guinea pigs].
    VISCHER WA
    Schweiz Z Pathol Bakteriol; 1956; 19(6):710-28. PubMed ID: 13421649
    [No Abstract]   [Full Text] [Related]  

  • 15. TUBERCULIN PRODUCTION. 2. COMPARISON BETWEEN AMOUNT OF TUBERCULIN OBTAINED FROMTHE CULTURE FILTRATE AND BY EXTRACTION OF TUBERCLE BACILLI.
    KIM HK; MAGNUSSON M; BENTZON MW
    Acta Pathol Microbiol Scand; 1963; 58():501-10. PubMed ID: 14048672
    [No Abstract]   [Full Text] [Related]  

  • 16. Studies on isoniazid and tubercle bacilli. III. The isolation, drug-susceptibility, and catalase-testing of tubercle bacilli from isoniazid-treated patients.
    MIDDLEBROOK G; COHN ML; SCHAEFER WB
    Am Rev Tuberc; 1954 Nov; 70(5):852-72. PubMed ID: 13207636
    [No Abstract]   [Full Text] [Related]  

  • 17. Some aspects of virulence of isoniazid-resistant tubercle bacilli.
    KANAI K; TAKAHASHI H; KATSUYAMA S; YANAGISAWA K
    Jpn J Med Sci Biol; 1955 Dec; 8(6):413-24. PubMed ID: 13345538
    [No Abstract]   [Full Text] [Related]  

  • 18. Some remarks concerning attenuated isoniazid-resistant strains of tubercle bacilli.
    JENSEN KA
    Acta Pathol Microbiol Scand; 1955; 37(1):71-8. PubMed ID: 14398264
    [No Abstract]   [Full Text] [Related]  

  • 19. [Frequency of tubercle bacilli strains with decreased sensitivity for isoniazid in non-treated tuberculosis in adults & children from 1953 to 1956].
    MEISSNER G
    Tuberkulosearzt; 1957 Oct; 11(10):645-8. PubMed ID: 13496264
    [No Abstract]   [Full Text] [Related]  

  • 20. [Catalase activity of isoniazid-resistant tubercle bacilli].
    SAENZ A
    Hoja Tisiol; 1959; 19():129-34. PubMed ID: 14440722
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.